Opioids for dyspnoea

Thorax

Volumn 57, Issue 11, 2002, Pages 922-923

  Muers, Martin F ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

DISEASE SEVERITY; DRUG EFFECT; DYSPNEA; LUNG GAS EXCHANGE; MONITORING; PRIORITY JOURNAL; REVIEW;

DYSPNEA; HUMANS; META-ANALYSIS; NARCOTICS; PALLIATIVE CARE;

EID: 0036846386     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.57.11.922     Document Type: Review

References (20)

1. Jennings AJ, Davies AN, Higgins JPT, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002; 57:939-44.
2. Mahler DA, Harver A, Lentine T, et al. Descriptors of breathlessness in cardiorespiratory disease. Am J Respir Crit Care Med 1996; 154:1357-63.
3. Amercian Thoracic Society. Dyspnoea: Mechanisms, assessment and management: A consensus statement. Am J Respir Crit Care Med 1999; 159:321-40.
4. Swinburn CR, Mould H, Stone TN, et al. Symptomatic benefit of supplemental oxygen in hypoxaemic patients with a chronic lung disease. Am Rev Respir Dis 1991; 143:913-8.
5. Sibuya M, Yamad AM, Kanamaura A, et al. The effect of chest wall vibration on dyspnoea in patients with chronic respiratory disease. Am J Respir Crit Care Med 1994; 149:1235-40.
6. British Thoracic Society Standards of Care Subcommittee on Pulmonary Rehabilitation. Pulmonary rehabilitation. Thorax 2001; 56:827-34.
7. Carrieri-Kohlman V, Douglas KN, Gromley JN, et al. Desensitisation and guided mastery: Treatment approaches for the management of dyspnoea. Heart Lung 1993; 22:226-34.
8. Schwartzstein RM, Lahive K, Pope A, et al. Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis 1987; 136:58-61.
9. Peiffer C, Poline J-B, Thivard L, et al. Neural substrates for the perception of acutely induced dyspnea. Am J Respir Crit Care Med 2001; 163:951-7.
10. Banzett RB, Mulnier HE, Murphy K, et al. Breathlessness in humans activates insular cortex. Neurol Rep 2000; 11:2117-20.
11. Coghill RC, Sang SN, Maisog JM, et al. Pain intensity processing within the human brain: A bilaterally distributed mechanism. J Neurol Physiol 1999; 82:1934-43.
12. Hseih J-C, Belfrage B, Stone-Elander S, et al. Central representation of chronic ongoing neuropathic pain studied by positron emission tomography. Pain 1995; 63:225-36.
13. Bruera E, MacEachern T, Ripamonti C, et al. Subcutaneous morphine for dyspnea in cancer patients. Am Intern Med 1993; 119:906-7.
14. Chua TP, Harrington D, Ponikowski P, et al. Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 1997; 29:147-52.
15. Johnson MA, Woodcock AA, Geddes DM. Dihydrocodeine for breathlessness in "pink puffers". BMJ 1983; 286:675-7.
16. Bredin M, Corner J, Krishnasamy M, et al. Multi-centre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ 1999; 318:901-4.
17. Royal College of Physicians. Domiciliary Oxygen Therapy Services: Clinical Guidelines and Advice for Prescribers. Report of a Working Party. London: Royal College of Physicians, 1999.
18. Woodcock AA, Grosse R, Geddes DM. Drug treatment of breathlessness: Contrasting effects of diazepam and promethazine in pink puffers. BMJ 1981; 283:343-6.
19. Rice KL, Kronenberg RS, Hedenar KLL, et al. The effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction. Br J Dis Chest 1987; 81:287-92.
20. Cohen MH, Anderson AJ, Krasnow SH, et al. Continuous intravenous infusion of morphine for severe dyspnea. South Med J 1991; 84:229-34.